Thin endometrium will lead to hypomenorrhea,infertility and recurrent pregnancy loss and there are few effective methods to increase the endometrial thickness and improve the fertility outcomes. Patients with thin endometrium will be divided into three groups and receive estrogen therapy, stem cell therapy and growth factor therapy respectively. This randomized controlled clinical study is carried out to explore the optimal treatment method and best indications for thin endometrium.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
345
CBD-bFGF will be injected into the endometrium after hysteroscopy under the guidance of ultrasound
A collagen scaffold loaded with BMMNCs will be transplanted into the uterine cavity after hysteroscopy under the guidance of ultrasound
Patients will receive regular estrogen therapy
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
RECRUITINGEndometrial thickness
Endometrial thickness evaluated by transvaginal sonography during late proliferative phase
Time frame: 6 months
Ongoing pregnancy rate
The presence of a living intrauterine fetus on TVU at the 12th week of gestation
Time frame: 24 months
Endometrial blood flow
Endometrial blood flow evaluated by transvaginal sonography
Time frame: 6 months
Pregnancy related complications
Miscarriage rate, live birth rate, ET cycle cancellation rate,Placenta related complications
Time frame: 24 months
Histological changes of endometrium
Histological changes of the thin endometrium before and after treatment
Time frame: 12 months
Menstrual blood volume
The change of menstrual blood volume after treatment compared with pre-treatment
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.